IDiyas

For the Inventor, By the Inventor

Plainsboro, NJ, United States of America

Michael H J Ohlmeyer

USPTO Granted Patents = 15

Average Co-Inventor Count = 10.4

ph-index = 3

Forward Citations = 108(Granted Patents)


Company Filing History:

goldMedal8 out of 52 
 
Pharmacopeia Drug Discovery, Inc.
 patents
silverMedal6 out of 100 
 
Berlex Laboratories, Inc.
 patents
bronzeMedal2 out of 101 
 
Pharmacopeia Inc.
 patents
4. 1 out of 2,487 
 
Columbia University
 patents
5. 1 out of 189 
 
Cold Spring Harbor Laboratory
 patents
6. 1 out of 1 
 
Berlax Laboratories, Inc.
 patent
7. 4 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2008

Loading Chart...
15 patents (USPTO):Explore Patents
1. 7365209 - Nitrogen heterocycle biaryls for osteoporosis and other diseases (2008-04-29),
2. 7037916 - Pyrimidine derivatives as IL-8 receptor antagonists (2006-05-02),
3. 6936477 - Complex combinatorial chemical libraries encoded with tags (2005-08-30),
4. 6919347 - Bradykinin B1 receptor antagonists (2005-07-19),
5. 6887865 - N-heterocyclic derivatives as NOS inhibitors (2005-05-03),
6. 6864368 - N-heterocyclic derivatives as NOS inhibitors (2005-03-08),
7. 6864263 - N-heterocyclic derivatives as NOS inhibitors (2005-03-08),
8. 6849739 - N-heterocyclic derivatives as NOS inhibitors (2005-02-01),
9. 6846829 - N-heterocyclic derivatives as NOS inhibitors (2005-01-25),
10. 6841674 - N-heterocyclic derivatives as NOS inhibitors (2005-01-11),
11. 6841673 - N-heterocyclic derivatives as nos inhibitors (2005-01-11),
12. 6747031 - N-heterocyclic derivatives as NOS inhibitors (2004-06-08),
13. 6670473 - N-heterocyclic derivatives as NOS inhibitors (2003-12-30),
14. 6503759 - Complex combinatorial chemical libraries encoded with tags (2003-01-07),
15. 6432947 - N-heterocyclic derivatives as NOS inhibitors (2002-08-13),

Title: Michael H J Ohlmeyer – Pioneering Innovations in Pharmaceutical Chemistry

Introduction

Michael H J Ohlmeyer is a notable inventor based in Plainsboro, NJ, United States. With a total of 15 patents to his name, he has made significant contributions to the field of pharmaceutical chemistry, particularly in developing compounds for treating a variety of diseases. His innovative work focuses on addressing pressing medical needs through cutting-edge chemical compounds.

Latest Patents

Among his latest patents, Ohlmeyer has developed novel nitrogen heterocycle biaryls for osteoporosis and other diseases. These compounds, characterized by a carboxylate terminus, are designed to treat conditions such as endometriosis, osteoporosis, rheumatoid arthritis, cancer, macular degeneration, and obesity. Additionally, he has worked on pyrimidine derivatives as Interleukin-8 receptor antagonists, which can be instrumental in managing diseases linked to inappropriate Interleukin-8 receptor activity.

Career Highlights

Ohlmeyer's career includes significant tenure at well-known organizations such as Pharmacopeia Drug Discovery, Inc. and Berlex Laboratories, Inc. His work at these companies has allowed him to explore innovative solutions and advance the science of drug discovery and development.

Collaborations

Throughout his career, Ohlmeyer has collaborated with several notable professionals, including John J Baldwin and Roland Ellwood Dolle. These partnerships have fostered a collaborative environment, further pushing the boundaries of innovation in pharmaceutical research.

Conclusion

Michael H J Ohlmeyer stands out as a dedicated inventor whose work continues to drive advancements in pharmaceuticals. With a robust portfolio of patents, he remains an integral player in the ongoing quest to develop effective treatments for various health conditions. His commitment to innovation and collaboration positions him as a key figure in the field of pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…